BCL-2 TARGETED STRUCTURAL BASED COMPUTER AIDED DRUG DESIGN (CAAD) FOR THERAPEUTIC ASSESSMENT OF RICIN IN PROSTATE CANCER. Int. J. Pharm. Sci. Drug Res. 2018, 7 (2), 168-171. https://doi.org/10.25004/IJPSDR.2015.070207.